Priya Rao - Concepedia

Author

Priya Rao

The University of Texas MD Anderson Cancer Center

Also Known As

Netto, George J., P.S. Raghavendra Rao, Priya Rao, Rohit Mehra, da Cunha, Isabela Werneck

Publications

862

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Cedars-Sinai Medical Center University of Chicago Ulsan College Methodist Hospital

About

Priya Rao is an author at The University of Texas MD Anderson Cancer Center specializing in urology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	425
2	Pathology	6	6	370
3	Health Sciences	2	2	25
4	Immunology	2	2	25
5	Nephrology	1	1	113

Priya Rao

Publications

670

Citations

H-Index

Page 1

	Year	Citations
Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder Gladell P. Paner, Chandrakanth Annaiah, Christian Gulmann, Human Pathology Urothelial DifferentiationUrologyUrological ResearchTraditional MarkersGenitourinary Cancer	2014	132
Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma? Joshua Weaver, Priya Rao, John R. Goldblum, Modern Pathology	2010	122
Primary Vascular Tumors and Tumor-like Lesions of the Kidney: A Clinicopathologic Analysis of 25 Cases Jeffrey G. Brown, Andrew L. Folpe, Priya Rao, The American Journal of Surgical Pathology Primary Vascular TumorsUrologyTumoral PathologyMedicineTumor-like Lesions	2010	113
Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract Christian Gulmann, Gladell P. Paner, Rugvedita Parakh, Human Pathology Urological ResearchUrologyTumoral PathologyGenitourinary CancerHistopathology	2012	84
Angiosarcoma Priya Rao, Guy Lahat, Christina A. Arnold, American Journal of Dermatopathology	2013	62
Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases Paari Murugan, Priya Rao, Pheroze Tamboli, Pathology & Oncology Research MedicineSurgical PathologyUrologyClinicopathologic Study	2017	42
‘Difficult to diagnose’ desmoid tumours: a potential role for <i>CTNNB1</i> mutational analysis Chiara Colombo, Svetlana Bolshakov, Shohrae Hajibashi, Histopathology	2011	41
Influence of Histologic Criteria and Confounding Factors in Staging Equivocal Cases for Microscopic Perivesical Tissue Invasion (pT3a) Vijayalakshmi Ananthanarayanan, Yi Pan, Maria Tretiakova, The American Journal of Surgical Pathology Surgical OncologyAdjuvant ChemotherapyPathologyMultimodalityConfounding Factors	2013	19
A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy (CN), metastasectomy (MS) or post-treatment biopsy (Bx). Jianjun Gao, José A. Karam, Nizar M. Tannir, Journal of Clinical Oncology Surgical OncologyImmunodeficienciesImmunologyImmunoeditingImmune Signatures	2018	13
A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy, metastasectomy or post-treatment biopsy (Bx). Jianjun Gao, José A. Karam, Nizar M. Tannir, Journal of Clinical Oncology Surgical OncologyImmunodeficienciesRenal PathologyImmunologyPathology	2019	12

Page 1